muscle
• at ~6 weeks, mutant skeletal muscles show loss of dystrophin, dystrobrevin, and the sarcoglycan-sarcospan complex
• during cycles of degeneration, satellite cells are repetitively activated leading to expression of dystroglycan and other components of the DGC in muscle fibers undergoing regeneration
|
• at ~6 weeks, mutant skeletal muscles, including quadriceps, gastrocnemius, tibialis anterior, biceps, gluteus maximus, and diaphragm, display myonecrosis
|
• surprisingly, aging mutants develop marked hypertrophy of skeletal muscle fibers
|
• a >2-fold increase in fiber diameter of the quadriceps and soleus muscle noted at 18 months
|
• at ~6 weeks, mutant mice show variation of skeletal muscle fiber size
|
• up to 95% of skeletal muscle fibers exhibit centrally located nuclei
|
• at 15 months, mutants show a widespread increase in wet muscle weight, esp. in the quadriceps and gastrocnemius muscles, where the weight is doubled
|
• at ~6 weeks, mutants exhibit hallmarks of muscular dystrophy, such as myonecrosis, central nucleation, and variation of fiber size
• however, despite ongoing cycles of muscle degeneration, aging mutants exhibit only a mild dystrophy with signs of efficient muscle regeneration and marked skeletal muscle hypertrophy but no signs of fibrosis or fat replacement
|
homeostasis/metabolism
• mutant mice exhibit significant elevation of serum creatine kinase levels
|
growth/size/body
• at 15 months, mutant mice are significantly larger than control littermates
|
cellular
• at ~6 weeks, mutant skeletal muscles, including quadriceps, gastrocnemius, tibialis anterior, biceps, gluteus maximus, and diaphragm, display myonecrosis
|